Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment
Rachel F. Buckley, Diana L. Townsend, Colin J. Birkenbihl, Madison Cuppels et autres
Importance: Blood-based biomarkers for Alzheimer disease, particularly plasma phosphorylated tau 217 (p-tau217), accurately reflect early Alzheimer disease brain pathology in cognitively unimpaired individuals, but estimates of absolute risk of progression to cognitive impairment across multiple cohorts are needed. Objective: To estimate absolute …
au, us, de, nl (code pays fourni par la source)
0 citations
JAMA